J P Gregoire

Summary

Country: Canada

Publications

  1. pmc Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients
    Mireille M Goetghebeur
    BioMedCom Consultants Inc, Dorval, Quebec, Canada
    Cost Eff Resour Alloc 8:4. 2010
  2. pmc Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec
    Alain Vanasse
    Department of Family Medicine, Faculty of Medicine, Universite de Sherbrooke, 3001 12th Avenue North, Sherbrooke QC, J1H 5N4, Canada
    BMC Musculoskelet Disord 6:33. 2005
  3. pmc Spatial variation in the management and outcomes of acute coronary syndrome
    Alain Vanasse
    Family Medicine Department, Faculty of Medicine, Universite de Sherbrooke, 3001, 12th Avenue North, Sherbrooke QC, Canada, J1H 5N4
    BMC Cardiovasc Disord 5:21. 2005
  4. doi Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study
    Jean Pierre Grégoire
    Faculty of Pharmacy, Universite Laval, Quebec, QC, Canada
    Value Health 13:820-8. 2010
  5. pmc Predictors of self-reported noncompliance with antihypertensive drug treatment: a prospective cohort study
    J Gregoire
    Faculty of Pharmacy and Population Health Research Unit, Universite Laval, Quebec, Canada
    Can J Cardiol 22:323-9. 2006
  6. pmc Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study
    Jean Pierre Grégoire
    Population Health Research Unit, Centre Hospitalier Affilie Universitaire De Quebec, 1050 Chemin Ste Foy, Quebec, QC, G1S 4L8, Canada
    BMC Health Serv Res 6:33. 2006
  7. ncbi Choice of initial antihypertensive medication and continuation of use
    J P Gregoire
    Faculte de Pharmacie, Cite Universitaire, Quebec, Canada
    Can J Cardiol 15:39F-41F. 1999
  8. ncbi Tolerability of antihypertensive drugs in a community-based setting
    J P Gregoire
    Epidemiology Research Group and Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada
    Clin Ther 23:715-26. 2001
  9. ncbi Appropriateness of omeprazole prescribing in Quebec's senior population
    J P Gregoire
    Faculté de Pharmacie et Groupe de recherche in epidémiologie, Universite Laval, Quebec
    Can J Gastroenterol 14:676-80. 2000
  10. ncbi Inter-provincial variation in government drug formularies
    J P Gregoire
    Faculte de Pharmacie, Groupe de Recherche en Epidemiologie, Universite Laval, Quebec
    Can J Public Health 92:307-12. 2001

Collaborators

Detail Information

Publications26

  1. pmc Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients
    Mireille M Goetghebeur
    BioMedCom Consultants Inc, Dorval, Quebec, Canada
    Cost Eff Resour Alloc 8:4. 2010
    ..Further testing and validation is needed to build up MCDA approaches combined with pragmatic HTA in healthcare decisionmaking...
  2. pmc Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec
    Alain Vanasse
    Department of Family Medicine, Faculty of Medicine, Universite de Sherbrooke, 3001 12th Avenue North, Sherbrooke QC, J1H 5N4, Canada
    BMC Musculoskelet Disord 6:33. 2005
    ..In this study, we identified potential predictors of bone mineral density (BMD) testing and OP treatment, which include place of residence...
  3. pmc Spatial variation in the management and outcomes of acute coronary syndrome
    Alain Vanasse
    Family Medicine Department, Faculty of Medicine, Universite de Sherbrooke, 3001, 12th Avenue North, Sherbrooke QC, Canada, J1H 5N4
    BMC Cardiovasc Disord 5:21. 2005
    ..We also assessed whether there was a relationship between ICP and HD, LoS, and EHR, and if the relationships varied spatially...
  4. doi Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study
    Jean Pierre Grégoire
    Faculty of Pharmacy, Universite Laval, Quebec, QC, Canada
    Value Health 13:820-8. 2010
    ..We assessed persistence patterns with oral antidiabetes drug (OAD) in patients newly dispensed with different OAD classes...
  5. pmc Predictors of self-reported noncompliance with antihypertensive drug treatment: a prospective cohort study
    J Gregoire
    Faculty of Pharmacy and Population Health Research Unit, Universite Laval, Quebec, Canada
    Can J Cardiol 22:323-9. 2006
    ..Persistence and compliance are different aspects of the broader concept of adherence to drug treatment. In a prior study, determinants of nonpersistence in a group of patients newly prescribed antihypertensive medications were examined...
  6. pmc Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study
    Jean Pierre Grégoire
    Population Health Research Unit, Centre Hospitalier Affilie Universitaire De Quebec, 1050 Chemin Ste Foy, Quebec, QC, G1S 4L8, Canada
    BMC Health Serv Res 6:33. 2006
    ..However, there is little evidence of their effectiveness. The objective of this study was to assess the impact of both a retrospective and a concurrent DUR programs on the quality of in-hospital prescribing...
  7. ncbi Choice of initial antihypertensive medication and continuation of use
    J P Gregoire
    Faculte de Pharmacie, Cite Universitaire, Quebec, Canada
    Can J Cardiol 15:39F-41F. 1999
    ..More research designed to assess the effectiveness of treatments in real life situations is needed. In particular, there is a need to clarify the role of side effects on continuation of initial treatment...
  8. ncbi Tolerability of antihypertensive drugs in a community-based setting
    J P Gregoire
    Epidemiology Research Group and Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada
    Clin Ther 23:715-26. 2001
    ..Outside the experimental environment of clinical trials, the tolerability of angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), and the angiotensin II antagonist losartan has not been compared...
  9. ncbi Appropriateness of omeprazole prescribing in Quebec's senior population
    J P Gregoire
    Faculté de Pharmacie et Groupe de recherche in epidémiologie, Universite Laval, Quebec
    Can J Gastroenterol 14:676-80. 2000
    ..In July 1993, the Quebec drug program listed omeprazole, with restriction, in its formulary. On January 1, 1994, this restriction was lifted; since then, omeprazole has been listed in the regular provincial formulary...
  10. ncbi Inter-provincial variation in government drug formularies
    J P Gregoire
    Faculte de Pharmacie, Groupe de Recherche en Epidemiologie, Universite Laval, Quebec
    Can J Public Health 92:307-12. 2001
    ..There is a wide variation across provinces in terms of NDM listed in the formularies. This variation reflects inter-provincial differences in the way drugs are selected for coverage...
  11. ncbi Health-related quality of life in hypertension: impact of a pharmacy intervention programme
    I Cote
    Population Health Research Unit, Faculty of Pharmacy, Universite Laval, Quebec, QC, Canada
    J Clin Pharm Ther 30:355-62. 2005
    ..The objective of the present study was to assess the effect of this pharmacy programme on the health-related quality of life (HRQOL) of individuals treated for hypertension...
  12. doi Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance
    L Guenette
    Faculty of Pharmacy, Universite Laval, Quebec, QC, Canada
    Diabetes Metab 39:250-7. 2013
    ..This study aimed to assess the 1-year treatment persistence and compliance of new oral antidiabetic drug (OAD) users with their treatment, and to identify the factors associated with both persistence and compliance...
  13. doi Underuse of cardioprotective treatment by the elderly with type 2 diabetes
    C Sirois
    Faculty of Pharmacy, Universite Laval, Quebec, Canada
    Diabetes Metab 34:169-76. 2008
    ....
  14. ncbi Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors
    C M Morin
    Ecole de Psychologie, Universite Laval, and Centre de recherche du CHA Hôpital du Saint Sacrement, Quebec City, Quebec, Canada
    Sleep Med 7:123-30. 2006
    ..To estimate the prevalence of insomnia symptoms and syndrome in the general population, describe the types of self-help treatments and consultations initiated for insomnia, and examine help-seeking determinants...
  15. pmc [International Prostate Symptom Scale. Evaluation of the usefulness of a French version]
    J Moisan
    Faculté de pharmacie de l Université Laval, Que
    Can Fam Physician 46:1772-6. 2000
    ....
  16. ncbi Non-compliance with drug treatment and reading difficulties with regard to prescription labelling among seniors
    Jocelyne Moisan
    Groupe de Recherche en Epidemiologie, Faculte de Pharmacie, Hopital du St Sacrement du CHA, Universite Laval, 1050 Chemin Ste Foy, Quebec, G1S 4L8 Canada
    Gerontology 48:44-51. 2002
    ..BACKGROUND; The link between experiencing difficulties in reading or understanding and non-compliance with drug treatment among seniors is not clearly established...
  17. pmc Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial
    Lucie Baillargeon
    Department of Family Medicine, Laval University, Sainte Foy, Que
    CMAJ 169:1015-20. 2003
    ..We compared the efficacy of tapering plus cognitive-behavioural therapy for insomnia with tapering alone in reducing the use of hypnotics by older adults with insomnia...
  18. ncbi Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec : a population-based utilization review
    R Blais
    Département d administration de la santé et Groupe de recherche interdisciplinaire en santé, Universite de Montreal, Montreal, Quebec, Canada
    Chest 119:1316-21. 2001
    ....
  19. doi Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents
    M Daley
    Ecole de Psychologie, Universite Laval, Quebec, Canada G1K 0A6
    Sleep Med 10:427-38. 2009
    ..To document and provide a micro analysis of the relationship between insomnia and health problems, health-care use, absenteeism, productivity and accidents...
  20. ncbi Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics: a population-based comparison of risperidone and olanzapine
    Jocelyne Moisan
    Faculty of Pharmacy, Universite Laval, Quebec, Que, Canada
    Pharmacoepidemiol Drug Saf 14:427-36. 2005
    ..To compare the incidence rates of diabetes mellitus and dyslipidemia in ambulatory first-time users of risperidone and olanzapine...
  21. ncbi Social context, the struggle with uncertainty, and subjective risk as meaning-rich constructs for explaining HBP noncompliance
    Michelle Proulx
    Equipe sur le Médicament Comme Objet Social et Culturel MEOS, Faculte de Pharmacie, Universite de Montreal, Canada
    Patient Educ Couns 68:98-106. 2007
    ..To identify the reasons for which people fail to take blood-pressure-lowering medication regularly, a qualitative study was conducted...
  22. ncbi [Factors associated with short- and long-term use of benzodiazepines in the elderly from Quebec]
    Dany Fortin
    Faculté de médecine de l Université de Sherbrooke et Centre de recherche sur le vieillissement de l Institut universitaire de geriatrie de Sherbrooke, 1036 rue Belvedere sud, Sherbrooke, QC, J1H 4C4, Canada
    Can J Aging 24:103-13. 2005
    ..In this study, we were unable to show a difference between the two groups of users with regards to the risk factors studied. This result leads us to conclude that prevention of long-term use must be aimed at all new benzodiazepine users...
  23. ncbi Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia
    Dan Cooper
    Faculte de Pharmacie, Universite Laval, Quebec City, Quebec
    Can J Psychiatry 50:901-8. 2005
    ..To assess treatment discontinuation and concomitant use of other antipsychotics among individuals initiated on olanzapine or risperidone for the treatment of schizophrenia...
  24. ncbi [Drug prescription practices in public medical centres in Gabon]
    Pamphile Gervais Nkogho Mengue
    Faculte de Pharmacie, Universite Laval, Unité de recherche en santé des populations, Centre Hospitalier Affilie Universitaire De Quebec, Quebec Canada
    Sante 15:229-34. 2005
    ..Inappropriate drug use constitutes a major problem of health programs in developing countries. The objective of this study was to describe and assess the quality of drug prescription practices in public medical centres in Gabon...
  25. ncbi A pharmacy-based health promotion programme in hypertension: cost-benefit analysis
    Isabelle Côté
    Faculty of Pharmacy, Laval University, Quebec, Canada
    Pharmacoeconomics 21:415-28. 2003
    ..This programme was developed to improve blood pressure control through activities aimed at improving the quality of prescribing and the adherence to treatment...
  26. ncbi Determinants of discontinuation of new courses of antihypertensive medications
    Jean Pierre Grégoire
    Faculté de pharmacie and Unité de recherche en santé des populations, Universite Laval, Quebec, Canada
    J Clin Epidemiol 55:728-35. 2002
    ..74; 95% CI 0.55-0.99). Persistence with newly prescribed medications could be improved by selecting antihypertensive medications containing fewer side effects and by lifting economic barriers to drug treatment...